Jürgen C. Becker

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

Keith T. Flaherty, Caroline Robert, Peter Hersey et al. · New England Journal of Medicine · 2012 · 2.1K citations · Full text

Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution

Line Pedersen, Manja Idorn, Gitte Holmen Olofsson et al. · Cell Metabolism · 2016 · 823 citations · Full text

Cancer Immunosurveillance, Tumor Microenvironment, Immunology +8

Germline mutations in BAP1 predispose to melanocytic tumors

Thomas Wiesner, Anna C. Obenauf, Rajmohan Murali et al. · Nature Genetics · 2011 · 711 citations

Melanoma, Pathology, Germline Mutations +4

Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma

Sean Whittaker, Marie‐France Demierre, Ellen J. Kim et al. · Journal of Clinical Oncology · 2010 · 650 citations

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG

Dirk Schadendorf, Selma Ugurel, Beatrice Schuler‐Thurner et al. · Annals of Oncology · 2006 · 466 citations · Full text

Cancer Immunosurveillance, Medicine, Melanoma +9